Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer symbols : QGEN save search
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
Published: 2024-04-03 (Crawled : 20:00) - globenewswire.com
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -1.05%
H: 0.8%
C: -0.87%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -1.05%
H: 0.8%
C: -0.87%
cancer meeting
Europe Cancer Diagnostics Market Sees Promising Growth Amid Rising Demand for Precision Diagnostics - Forecasts to 2031
Published: 2024-03-01 (Crawled : 00:20) - prnewswire.com
QGEN | $41.505 -0.92% 610K
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.505 -0.92% 610K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $122.395 -1.66% 510K
|
Health Technology
| Email alert
Add to watchlist
CAJFF | $29.0664 -28.15% 760
|
Electronic Technology
| Email alert
Add to watchlist
CAJPY | $28.73 39K
|
n/a
| Email alert
Add to watchlist
HOLX | $76.94 -0.32% 420K
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $576.17 0.27% 1.5M
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
| Email alert
Add to watchlist
europe precision cancer diagnostics growth market
Liquid Biopsy Market Set to Reach US$ 10.08 Billion by 2030 with Pioneering Breakthroughs in Cancer Detection and Management
Published: 2024-02-16 (Crawled : 19:00) - prnewswire.com
TMO | News | $576.17 0.27% 1.5M
|
Health Technology
| Email alert
Add to watchlist
EXAS | $63.72 0.3% 540K
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.505 -0.92% 610K
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.505 -0.92% 610K
|
Health Technology
| Email alert
Add to watchlist
LH M | $207.745 -0.11% 470K
|
Health Services
| Email alert
Add to watchlist
ILMN | $122.395 -1.66% 510K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $148.66 -0.6% 5.2M
|
Health Technology
| Email alert
Add to watchlist
management reach cancer set market
Clinical Biomarkers Market Analysis and Forecast, 2023-2033 - Cancer Biomarkers to Witness the Highest Growth between 2023 and 2033
Published: 2024-02-13 (Crawled : 03:00) - prnewswire.com
TMO | News | $576.17 0.27% 1.5M
|
Health Technology
|
| O: -0.99%
H: 0.88%
C: -0.52%
DGX | News | $137.64 0.69% 970K
|
Health Services
|
| O: 0.01%
H: 0.55%
C: -1.66%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -1.64%
H: 0.58%
C: -0.56%
BIO | $278.77 -2.28% 140K
|
Health Technology
|
| O: -1.32%
H: 0.37%
C: -1.83%
BDX | $234.07 -0.12% 480K
|
Health Technology
|
| O: 0.04%
H: 0.72%
C: -1.81%
A | $137.41 -1.29% 890K
|
Health Technology
|
| O: -2.03%
H: 1.0%
C: -0.44%
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
|
| O: 0.94%
H: 0.0%
C: 0.0%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -1.64%
H: 0.58%
C: -0.56%
MYGN | $18.65 0.27% 220K
|
Health Technology
|
| O: -3.99%
H: 1.49%
C: -3.71%
ILMN | $122.395 -1.66% 510K
|
Health Technology
|
| O: -2.48%
H: 1.08%
C: -2.01%
CNTG | $0.475 -1.04% 18K
|
Commercial Services
|
| O: 2.59%
H: 0.0%
C: -11.11%
cancer biomarkers growth market
Cancer Biopsy Market Share is Expected to Reach USD 92.09 Billion By 2032, Growing at 14.8% CAGR: Polaris Market Research
Published: 2023-11-27 (Crawled : 15:30) - prnewswire.com
TMO | News | $576.17 0.27% 1.5M
|
Health Technology
|
| O: 0.1%
H: 0.86%
C: 0.19%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.37%
H: 0.46%
C: -1.1%
PHG | News | $20.985 -0.12% 430K
|
Health Technology
|
| O: 0.09%
H: 0.7%
C: 0.47%
DHR | $249.74 -1.33% 1.6M
|
Health Technology
|
| O: -0.41%
H: 0.67%
C: -0.23%
BIO | $278.77 -2.28% 140K
|
Health Technology
|
| O: -0.71%
H: 0.05%
C: -0.6%
BDX | $234.07 -0.12% 480K
|
Health Technology
|
| O: -0.1%
H: 0.73%
C: 0.08%
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
|
| O: -0.2%
H: 0.85%
C: 0.11%
VCYT | News | $19.815 -0.08% 230K
|
Health Technology
|
| O: -0.95%
H: 2.93%
C: 1.66%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.37%
H: 0.46%
C: -1.1%
NEO | $13.93 -1.62% 350K
|
Health Services
|
| O: -0.16%
H: 0.21%
C: -1.14%
MYGN | $18.65 0.27% 220K
|
Health Technology
|
| O: -0.55%
H: 1.45%
C: 0.5%
ILMN | $122.395 -1.66% 510K
|
Health Technology
|
| O: -1.5%
H: 0.97%
C: -2.28%
HOLX | $76.94 -0.32% 420K
|
Health Technology
|
| O: -0.42%
H: 0.43%
C: 0.13%
expected reach cancer research growing market
QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
Published: 2023-10-26 (Crawled : 12:00) - globenewswire.com
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -0.08%
H: 0.41%
C: -0.14%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -0.08%
H: 0.41%
C: -0.14%
MYGN | $18.65 0.27% 220K
|
Health Technology
|
| O: 0.75%
H: 0.81%
C: -3.99%
cancer companion diagnostics
QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023
Published: 2023-04-14 (Crawled : 11:00) - biospace.com/
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -0.3%
H: 0.34%
C: -0.21%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -0.3%
H: 0.34%
C: -0.21%
cancer research meeting
The Global Cancer Biomarkers Market to Upsurge at a Tremendous CAGR of ~14% by 2027 | DelveInsight
Published: 2023-02-13 (Crawled : 16:00) - prnewswire.com
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -1.34%
H: 1.01%
C: 0.6%
BIO | $278.77 -2.28% 140K
|
Health Technology
|
| O: 0.45%
H: 0.68%
C: -0.29%
ABBV | News | $168.055 -0.88% 1.8M
|
Health Technology
|
| O: -0.02%
H: 1.16%
C: 1.12%
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
|
| O: 0.15%
H: 0.76%
C: 0.18%
SNY | News | $46.765 -1.94% 1.2M
|
Health Technology
|
| O: -1.53%
H: 0.0%
C: 0.0%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -1.34%
H: 1.01%
C: 0.6%
ILMN | $122.395 -1.66% 510K
|
Health Technology
|
| O: 0.17%
H: 9.75%
C: 9.66%
HOLX | $76.94 -0.32% 420K
|
Health Technology
|
| O: 0.23%
H: 1.74%
C: 1.72%
EXAS | $63.72 0.3% 540K
|
Health Technology
|
| O: 0.55%
H: 1.69%
C: 1.57%
CNTG | $0.475 -1.04% 18K
|
Commercial Services
|
| O: 0.0%
H: 3.88%
C: -1.55%
global biomarkers cancer market
QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer
Published: 2022-12-13 (Crawled : 11:00) - biospace.com/
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 2.13%
H: 0.3%
C: -2.2%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 2.13%
H: 0.3%
C: -2.2%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 1.16%
H: 1.41%
C: 0.19%
fda lung diagnostic approval cancer
Cancer Biomarkers Market to Exceed US$ 34 Billion by 2032 as Need for Early Detection in Lung & Prostate Cancer Rises
Published: 2022-11-23 (Crawled : 15:20) - prnewswire.com
TMO | News | $576.17 0.27% 1.5M
|
Health Technology
|
| O: 1.02%
H: 0.0%
C: 0.0%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.33%
H: 1.36%
C: 0.91%
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
|
| O: 0.1%
H: 1.43%
C: 1.0%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.33%
H: 1.36%
C: 0.91%
lung biomarkers cancer market prostate cancer
Cancer/Tumor Profiling Market worth $16.0 billion by 2027 - Exclusive Report by MarketsandMarkets™
Published: 2022-11-08 (Crawled : 16:00) - prnewswire.com
TMO | News | $576.17 0.27% 1.5M
|
Health Technology
|
| O: 0.44%
H: 1.31%
C: -0.42%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 4.08%
H: 3.3%
C: 1.47%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 4.08%
H: 3.3%
C: 1.47%
NSTG M | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -17.68%
H: 2.9%
C: -18.05%
ILMN | $122.395 -1.66% 510K
|
Health Technology
|
| O: 0.37%
H: 2.1%
C: 0.02%
HTGM | $0.48 -20.0% -26.08% 0
|
Health Technology
|
| O: -1.01%
H: 7.06%
C: 3.06%
GH | News 4 | $17.935 3.43% 930K
|
Health Services
|
| O: -0.85%
H: 1.54%
C: -5.24%
report market cancer
Hereditary Cancer Testing Market to Reach USD 10.1 Billion, Globally, by 2031 at 11.6% CAGR, Says Allied Market Research
Published: 2022-10-14 (Crawled : 16:00) - prnewswire.com
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 1.42%
H: 1.15%
C: -1.73%
DHR | $249.74 -1.33% 1.6M
|
Health Technology
|
| O: 0.65%
H: 0.71%
C: -2.02%
BIO | $278.77 -2.28% 140K
|
Health Technology
|
| O: 0.59%
H: 0.99%
C: -0.63%
A | $137.41 -1.29% 890K
|
Health Technology
|
| O: 0.86%
H: 0.95%
C: -2.56%
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
|
| O: 0.69%
H: 0.72%
C: -2.2%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 1.42%
H: 1.15%
C: -1.73%
MYGN | $18.65 0.27% 220K
|
Health Technology
|
| O: 1.2%
H: 0.41%
C: -3.76%
ILMN | $122.395 -1.66% 510K
|
Health Technology
|
| O: 0.88%
H: 0.8%
C: -2.5%
research cancer market
Cervical Cancer Diagnostic Global Market Report 2022: Increasing Accuracy of Pap Smear Tests Boosts Industry
Published: 2022-10-06 (Crawled : 17:00) - prnewswire.com
GTHP J | $0.108 5.2K
|
Manufacturing
|
| O: -5.62%
H: 0.0%
C: -0.66%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.85%
H: 0.61%
C: 0.09%
PKX | News | $71.5 0.03% 130K
|
Non-Energy Minerals
|
| O: -0.13%
H: 0.94%
C: -0.2%
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
|
| O: -0.5%
H: 0.34%
C: -0.4%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.85%
H: 0.61%
C: 0.09%
global report diagnostic cancer market
Cancer Biomarkers Market to Exceed Value of US$ 31.4 Bn by 2031, States TMR Report
Published: 2022-09-20 (Crawled : 03:00) - prnewswire.com
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: 1.96%
H: 0.0%
C: 0.0%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -1.12%
H: 1.02%
C: 0.65%
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -0.19%
H: 0.0%
C: 0.0%
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
|
| O: -0.82%
H: 0.07%
C: -0.61%
BMY | $48.875 -0.24% 11M
|
Health Technology
|
| O: -0.56%
H: 0.37%
C: -0.1%
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
|
| O: -1.25%
H: 0.23%
C: -0.47%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -1.12%
H: 1.02%
C: 0.65%
HOLX | $76.94 -0.32% 420K
|
Health Technology
|
| O: -0.71%
H: 0.23%
C: -2.27%
EXAS | $63.72 0.3% 540K
|
Health Technology
|
| O: -1.3%
H: 2.67%
C: 0.0%
report biomarkers cancer market
Global $3.25+ Billion Lung Cancer Genomic Testing Markets to 2031: Focus on Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
Published: 2022-06-23 (Crawled : 11:00) - prnewswire.com
DGX | News | $137.64 0.69% 970K
|
Health Services
|
| O: 0.43%
H: 2.47%
C: 1.85%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
LH M | $207.745 -0.11% 470K
|
Health Services
|
| O: 2.35%
H: 2.94%
C: 2.21%
NVTA | News | $0.019 0.0% 22M
|
Health Services
|
| O: 0.4%
H: 13.31%
C: 13.31%
A | $137.41 -1.29% 890K
|
Health Technology
|
| O: 1.38%
H: 3.62%
C: 3.49%
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
|
| O: 2.4%
H: 0.0%
C: 0.0%
VCYT | News | $19.815 -0.08% 230K
|
Health Technology
|
| O: 0.75%
H: 15.68%
C: 15.57%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
OPK | $1.225 -2.0% 5.2M
|
Health Technology
|
| O: 0.0%
H: 6.02%
C: 5.62%
ILMN | $122.395 -1.66% 510K
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: 0.0%
CNTG | $0.475 -1.04% 18K
|
Commercial Services
|
| O: -4.76%
H: 34.5%
C: 3.0%
genomic cancer
At 19.9% CAGR, Global Breast Cancer Liquid Biopsy Market Size & Share to Surpass USD 357.05 Million by 2028 | Industry Trends, Growth, Value, Opportunities, Statistics, Analysis & Forecast Report by Zion Market Research
Published: 2022-06-20 (Crawled : 15:20) - prnewswire.com
TMO | News | $576.17 0.27% 1.5M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.505 -0.92% 610K
|
Health Technology
| Email alert
Add to watchlist
PSNL | $1.31 -5.07% 160K
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.505 -0.92% 610K
|
Health Technology
| Email alert
Add to watchlist
research report cancer market breast cancer
Sysmex Inostics & QIAGEN Highlight Cancer Companion Diagnostics Alliance at ASCO 2022
Published: 2022-06-02 (Crawled : 16:00) - biospace.com/
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -0.09%
H: 2.93%
C: 2.84%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -0.09%
H: 2.93%
C: 2.84%
diagnostics asco cancer diagnostic
Next-Generation Gynecological Cancer Diagnostics Market, 2031
Published: 2022-04-27 (Crawled : 10:00) - prnewswire.com
TMO | News | $576.17 0.27% 1.5M
|
Health Technology
|
| O: -2.87%
H: 0.0%
C: 0.0%
DGX | News | $137.64 0.69% 970K
|
Health Services
|
| O: -0.43%
H: 3.45%
C: 1.79%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.91%
H: 1.37%
C: 0.09%
LH M | $207.745 -0.11% 470K
|
Health Services
|
| O: -3.91%
H: 2.25%
C: 1.17%
NVTA | News | $0.019 0.0% 22M
|
Health Services
|
| O: -6.95%
H: 4.32%
C: -1.38%
A | $137.41 -1.29% 890K
|
Health Technology
|
| O: -2.2%
H: 2.24%
C: -0.44%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.91%
H: 1.37%
C: 0.09%
OPK | $1.225 -2.0% 5.2M
|
Health Technology
|
| O: -6.64%
H: 1.78%
C: -1.42%
MYGN | $18.65 0.27% 220K
|
Health Technology
|
| O: -2.62%
H: 3.04%
C: 0.09%
ILMN | $122.395 -1.66% 510K
|
Health Technology
|
| O: -3.78%
H: 2.05%
C: -1.05%
FLGT | $20.545 -0.46% 72K
|
Health Services
|
| O: -3.5%
H: 3.75%
C: 0.29%
CNTG | $0.475 -1.04% 18K
|
Commercial Services
|
| O: -2.84%
H: 1.46%
C: -1.17%
diagnostics cancer diagnostic
Global Cancer Biomarkers Market Research Report 2022
Published: 2022-04-21 (Crawled : 12:20) - prnewswire.com
TMO | News | $576.17 0.27% 1.5M
|
Health Technology
|
| O: 2.95%
H: 0.0%
C: 0.0%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: 2.81%
H: 0.0%
C: 0.0%
BIO | $278.77 -2.28% 140K
|
Health Technology
|
| O: 1.54%
H: 0.0%
C: 0.0%
BDX | $234.07 -0.12% 480K
|
Health Technology
|
| O: 1.5%
H: 0.0%
C: 0.0%
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
|
| O: 3.21%
H: 0.0%
C: 0.0%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
MYGN | $18.65 0.27% 220K
|
Health Technology
|
| O: 1.31%
H: 0.0%
C: 0.0%
ILMN | $122.395 -1.66% 510K
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
HOLX | $76.94 -0.32% 420K
|
Health Technology
|
| O: 2.17%
H: 0.0%
C: 0.0%
CNTG | $0.475 -1.04% 18K
|
Commercial Services
|
| O: -2.66%
H: 1.25%
C: 1.25%
research report cancer market biomarkers
Cancer Biomarkers Market worth $28.2 billion by 2026 - Exclusive Report by MarketsandMarkets™
Published: 2022-03-18 (Crawled : 16:00) - prnewswire.com
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -1.76%
H: 4.73%
C: 4.13%
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -0.43%
H: 2.91%
C: 2.7%
BIO | $278.77 -2.28% 140K
|
Health Technology
|
| O: -0.66%
H: 3.27%
C: 3.01%
BDX | $234.07 -0.12% 480K
|
Health Technology
|
| O: 0.68%
H: 0.55%
C: 0.24%
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -1.76%
H: 4.73%
C: 4.13%
MYGN | $18.65 0.27% 220K
|
Health Technology
|
| O: -0.32%
H: 5.68%
C: 3.46%
ILMN | $122.395 -1.66% 510K
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
HOLX | $76.94 -0.32% 420K
|
Health Technology
|
| O: 0.24%
H: 1.24%
C: 1.12%
CNTG | $0.475 -1.04% 18K
|
Commercial Services
|
| O: 0.0%
H: 3.0%
C: 2.75%
report cancer biomarkers
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
SKIL 4 | $8.72 52.72% 410K
|
Information
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
RILY | $29.755 36.99% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.